Vascular Graft Market By Raw Material 2022 | IndustryARC
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Vascular Graft Market
Vascular Graft Market: By Raw Material (Polyester, Polytetrafluoroethylene, Others); By Product (Hemodialysis Access, Endovascular Stent, Others); By Application (Cardiovascular Diseases, Cardiac Aneurysm, Others) & By Region-Forecast (2016-2022)
Report Code : HCR 0714
Published: 22 September, 2016   No. of pages: 136

  • Report Description
  • Table of Contents
  • Customization Options
Vascular graft procedures are minimally invasive besides involving repairing vessels from the inside as compared to other conventional vascular surgical procedure. In vascular graft procedures, Catheter-based devices are introduced through a minor incision and are directed with the aid of real-time imaging technologies. Globally, development of efficient and advanced novel products using tissue engineered, and biological materials, rise in the awareness among people regarding peripheral artery diseases and coronary diseases, increasing government initiatives across the globe, growing prevalence of cardiovascular diseases such as hypertension, coronary artery disease, and cardiac aneurysms, and increasing prevalence of diabetes around the world are the prime growth drivers of the vascular graft market. In addition, an increase in adoption of vascular graft in emerging economies such as China, India and others, will create new opportunities for the vascular graft market. However, higher cost of the research and development, and higher cost of vascular graft procedures are the key restraints for the vascular graft market.

 Vascular Graft Market

Geographically, North America dominated the vascular graft market, due to high medical reimbursement facilities, and technological advancement. Asia Pacific is projected to have the fastest growth, owing to a rapidly increasing geriatric population, rise in consumer awareness, increasing healthcare expenditure, favourable government policies, modernization of healthcare infrastructure, and growing medical tourism industry in developing nations such as China, and India in this region. Among all the applications, cardiovascular diseases has the highest market share in the vascular graft market due to higher prevalence of hypertension, high blood sugar and other age-related risk factors.

This report identifies the vascular graft market size for the years 2014-2016, and forecast of the same till the year 2022. It also highlights the market drivers, restraints, growth indicators, challenges, and other key aspects with respect to the vascular graft market.

This report segments the vascular graft market on the basis of raw material, product, application, and regional market as follows:
  • Vascular Graft Market, By Raw Material: Polyester, Polytetrafluoroethylene, Polyurethane, and Biological Materials
  • Vascular Graft Market, By Product: Hemodialysis Access Graft, Endovascular Stent Graft, Peripheral vascular, and Coronary Artery By-pass Graft
  • The report has focused study on vascular graft market on the basis of application such as: Cardiovascular Diseases, Cardiac Aneurysm, Kidney Failure,  and Vascular Occlusion
  • This report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region

This report identifies all the major companies operating in the vascular graft market. Some of the major companies’ profiles in detail are as follows:
  • Medtronic Inc.
  • Bard Peripheral Vascular Inc. 
  • Shanghai Suokang Medical Implants Co., Ltd
  • W.L. Gore & Associates
  • Junken Medical Co., Ltd.
1. Vascular Graft Market – Overview
2. Executive Summary 
3. Vascular Graft Market Landscape
   3.1. Market Share Analysis
   3.2. Comparative Analysis
   3.3. Product Benchmarking
   3.4. End User Profiling
   3.5. Top 5 Financials Analysis
4. Vascular Graft Market– Forces
   4.1. Drivers
      4.1.1. Development of efficient and advance novel products using tissue engineered, and biological materials
      4.1.2. Growing prevalence of cardiovascular diseases such as hypertension, coronary artery disease, and cardiac aneurysms
   4.2. Restraints
      4.2.1. Higher cost of research and development 
   4.3. Opportunities
      4.3.1. Emerging economies
   4.4. Challenges
   4.5. Porter’s Five Forces Analysis
      4.5.1. Bargaining Power of Suppliers
      4.5.2. Bargaining Power of Buyers
      4.5.3. Threat of New Entrants
      4.5.4. Threat of Substitutes
      4.5.5. Degree of Competition
5. Vascular Graft Market– Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Pricing Analysis
   5.3. Opportunities Analysis
   5.4. Product/Market Life Cycle Analysis
   5.5. Suppliers and Distributors
6. Vascular Graft Market, By Raw Material
   6.1. Polyester
   6.2. Polytetrafluoroethylene
   6.3. Polyurethane
   6.4. Biological Materials 
7. Vascular Graft Market, By Product
   7.1. Hemodialysis Access Graft
   7.2. Endovascular Stent Graft
   7.3. Peripheral Vascular
   7.4. Coronary Artery By-Pass Graft
8. Vascular Graft Market, By Application 
   8.1. Cardiovascular Diseases
   8.2. Cardiac Aneurysm
   8.3. Kidney Failure
   8.4. Vascular Occlusion
9. Vascular Graft Market, By Geography
   9.1. Europe
      9.1.1. Germany
      9.1.2. France
      9.1.3. Italy
      9.1.4. Spain
      9.1.5. Russia
      9.1.6. U.K.
      9.1.7. Rest of Europe
   9.2. Asia Pacific
      9.2.1. China
      9.2.2. India
      9.2.3. Japan
      9.2.4. South Korea
      9.2.5. Rest of Asia-Pacific
   9.3. North America 
      9.3.1. U.S.
      9.3.2. Canada
      9.3.3. Mexico
   9.4. Rest of the World (RoW)
      9.4.1. Brazil
      9.4.2. Rest of RoW
10. Vascular Graft Market– Entropy
   10.1. Expansion
   10.2. Technological Developments
   10.3. Merger & Acquisitions, and Joint Ventures
   10.4. Supply- Contract
11. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)
   11.1. Medtronic Inc.
   11.2. Bard Peripheral Vascular Inc. 
   11.3. Shanghai Suokang Medical Implants Co., Ltd
   11.4. W.L. Gore & Associates
   11.5. Junken Medical Co., Ltd.
   11.6. Getinge Group
   11.7. Cook Medical
   11.8. LeMaitre Vascular Inc.
   11.9. Humacyte, Inc.
   11.10. Terumo Medical Corporation
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
12. Appendix
   12.1. Abbreviations
   12.2. Sources
   12.3. Research Methodology
   12.4. Bibliography
   12.5. Compilation of Expert Insights
   12.6. Disclaimer
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports